Paul Parker, firmwide chair of Perkins Coie’s Medical Device industry sector, has over 20 years of experience and focuses his practice on emerging medical device companies, with particular experience in cardiovascular, renal neuromodulation, neurostimulation, spinal devices and aesthetic treatments. Paul has represented investors and emerging companies from incubation through acquisition/IPO. In the past two years, he was involved in raising over $100 million in venture funding for emerging medical device companies and has been involved in over $1 billion in acquisitions/IPOs since 2010. Paul also has extensive experience in portfolio development and patent strategies, freedom to operate analyses and other intellectual property due diligence, patent licensing and technology transfer.
Ranked by Chambers USA 17 Years in a Row
Intellectual Property
Professional Recognition
- Named IAM Global Leader, 2020 – 2024
- Listed in LMG Life Sciences 2019 as an "Intellectual Property Star"
- Highly recommended in Intellectual Asset Management Patent 1000, 2012 – 2023
- Recognized as an IP Star by Managing IP, 2013, 2014, 2016 – 2022
- Listed in Super Lawyers Magazine, “Washington’s Super Lawyers," 2001 – 2018
- Listed in Seattle Magazine, “Seattle’s Best Lawyers," 2003
- Ranked by Chambers USA as “America’s Leading Lawyer" for Intellectual Property, 2007 – 2023
- Listed in Best Lawyers in America: Litigation - Intellectual Property; Litigation - Patent; Patent Law, 2009 – 2024
Related Employment
- Seed & Berry, Seattle, WA, Associate, 1995 – 1999
- Fredrikson & Byron, P.A., Minneapolis, MN, Associate, 1993 – 1995